Gene · 6422
Papers4,318
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 4,318
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Discovery and identification of the prognostic significance and potential mechanism of FMO2 in breast cancer. | Aging (Albany NY) | 2023 | 37963835 | PubTator, text mining | PubMed |
| Analysis of the impact of the combined use of rebar bolts and FRP bolts in the roadway enclosure. | Sci Rep | 2023 | 37949925 | PubTator, text mining | PubMed |
| Deconstruction of rheumatoid arthritis synovium defines inflammatory subtypes. | Nature | 2023 | 37938773 | PubTator, text mining | PubMed |
| The m6A/m1A/m5C-Related Methylation Modification Patterns and Immune Landscapes in Rheumatoid Arthritis and Osteoarthritis Revealed by Microarray and Single-Cell Transcriptome. | J Inflamm Res | 2023 | 37933335 | PubTator, text mining | PubMed |
| Precision medicine in nasopharyngeal carcinoma: comprehensive review of past, present, and future prospect. | J Transl Med | 2023 | 37932756 | PubTator, text mining | PubMed |
| Transitional cell states sculpt tissue topology during lung regeneration. | Cell Stem Cell | 2023 | 37922879 | PubTator, text mining | PubMed |
| Human dermal fibroblast subpopulations and epithelial mesenchymal transition signals in hidradenitis suppurativa tunnels are normalized by spleen tyrosine kinase antagonism in vivo. | PLoS One | 2023 | 37922232 | PubTator, text mining | PubMed |
| A novel anoikis-related gene signature predicts prognosis in patients with breast cancer and reveals immune infiltration. | Medicine (Baltimore) | 2023 | 37904416 | PubTator, text mining | PubMed |
| Luminal breast cancer identity is determined by loss of glucocorticoid receptor activity. | EMBO Mol Med | 2023 | 37902007 | PubTator, text mining | PubMed |
| Epigenetic regulation in lung cancer. | MedComm (2020) | 2023 | 37901797 | PubTator, text mining | PubMed |
| Parametric Optimization of Torsional Parameters of Ferrocement "U" Wrapped Beams Using Recent Meta-Heuristic Optimization Algorithms. | Materials (Basel) | 2023 | 37895708 | PubTator, text mining | PubMed |
| Prognostic Factors and Markers in Non-Small Cell Lung Cancer: Recent Progress and Future Challenges. | Genes (Basel) | 2023 | 37895255 | PubTator, text mining | PubMed |
| Oncomeric Profiles of microRNAs as New Therapeutic Targets for Treatment of Ewing's Sarcoma: A Composite Review. | Genes (Basel) | 2023 | 37895198 | PubTator, text mining | PubMed |
| Cultured Mesenchymal Cells from Nasal Turbinate as a Cellular Model of the Neurodevelopmental Component of Schizophrenia Etiology. | Int J Mol Sci | 2023 | 37895019 | PubTator, text mining | PubMed |
| Extracellular Vesicles Derived from Osteogenic-Differentiated Human Bone Marrow-Derived Mesenchymal Cells Rescue Osteogenic Ability of Bone Marrow-Derived Mesenchymal Cells Impaired by Hypoxia. | Biomedicines | 2023 | 37893177 | PubTator, text mining | PubMed |
| Role of Non-Coding RNAs in TGF-β Signalling in Glioma. | Brain Sci | 2023 | 37891744 | PubTator, text mining | PubMed |
| Light-Induced Polymeric Frustrated Radical Pairs as Building Blocks for Materials and Photocatalysts. | J Am Chem Soc | 2023 | 37890166 | PubTator, text mining | PubMed |
| Regulation of self-renewal and senescence in primitive mesenchymal stem cells by Wnt and TGFβ signaling. | Stem Cell Res Ther | 2023 | 37880755 | PubTator, text mining | PubMed |
| Human cerebrospinal fluid affects chemoradiotherapy sensitivities in tumor cells from patients with glioblastoma. | Sci Adv | 2023 | 37878712 | PubTator, text mining | PubMed |
| The BAF chromatin remodeling complex licenses planarian stem cells access to ectodermal and mesodermal cell fates. | BMC Biol | 2023 | 37864247 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6422/papers?page=14